During the past decade, Cancer Care Centers of South Texas conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 54 clinical trials were completed, i.e. on average, 245.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 20 clinical trials were completed. i.e. 2000% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Centers of South Texas" #1 sponsor was "Bristol-Myers Squibb" with 10 trials, followed by "Celgene" with 7 trials sponsored, "Radiation Therapy Oncology Group" with 7 trials sponsored, "Novartis Pharmaceuticals" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Centers of South Texas" #1 collaborator was "NRG Oncology" with 10 trials as a collaborator, "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Sanofi" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Centers of South Texas" are "Breast Cancer" (18 trials), "Multiple Myeloma" (7 trials), "Metastatic Breast Cancer" (6 trials), "Myelodysplastic Syndrome" (5 trials) and "Myelodysplastic Syndromes" (4 trials). Many other conditions were trialed in "Cancer Care Centers of South Texas" in a lesser frequency.

Most popular intervention types in "Cancer Care Centers of South Texas" are "Drug" (84 trials), "Biological" (12 trials), "Other" (10 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (10 trials), "Carboplatin" (9 trials), "Placebo" (8 trials), "Dexamethasone" (5 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Centers of South Texas" are 74 trials for "All" genders, 24 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Care Centers of South Texas". undefined are not yet recruiting, 2 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in Cancer Care Centers of South Texas, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Centers of South Texas, 14 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".